Compare Siemens Healthineers AG with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
EUR 46,699 Million ()
21.00
NA
4.71%
0.81
12.73%
2.53
Revenue and Profits:
Net Sales:
6,322 Million
(Quarterly Results - Sep 2025)
Net Profit:
597 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.53%
0%
-6.53%
6 Months
-9.23%
0%
-9.23%
1 Year
-27.55%
0%
-27.55%
2 Years
-22.56%
0%
-22.56%
3 Years
-21.47%
0%
-21.47%
4 Years
-27.44%
0%
-27.44%
5 Years
-16.13%
0%
-16.13%
Siemens Healthineers AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.58%
EBIT Growth (5y)
8.50%
EBIT to Interest (avg)
18.12
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.62
Tax Ratio
24.22%
Dividend Payout Ratio
52.23%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.64%
ROE (avg)
11.15%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
3.05
EV to EBIT
17.68
EV to EBITDA
13.16
EV to Capital Employed
2.19
EV to Sales
2.85
PEG Ratio
0.94
Dividend Yield
1.99%
ROCE (Latest)
12.37%
ROE (Latest)
14.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
6,322.00
6,329.00
-0.11%
Operating Profit (PBDIT) excl Other Income
1,246.00
1,586.00
-21.44%
Interest
108.00
142.00
-23.94%
Exceptional Items
-38.00
-327.00
88.38%
Consolidate Net Profit
597.00
624.00
-4.33%
Operating Profit Margin (Excl OI)
148.40%
201.80%
-5.34%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -0.11% vs 4.51% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -4.33% vs 15.56% in Sep 2024
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
23,375.00
22,363.00
4.53%
Operating Profit (PBDIT) excl Other Income
4,731.00
4,523.00
4.60%
Interest
425.00
476.00
-10.71%
Exceptional Items
-250.00
-431.00
42.00%
Consolidate Net Profit
2,168.00
1,959.00
10.67%
Operating Profit Margin (Excl OI)
147.00%
147.60%
-0.06%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 4.53% vs 3.15% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is 10.67% vs 28.46% in Sep 2024
About Siemens Healthineers AG 
Siemens Healthineers AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






